To conclude, The high expression of AKR1B10 in hepatocellular carcinoma (HCC) is not only associated with significant clinical and pathological features but may also influence the progression and prognosis of HCC by activating key signaling pathways and altering the tumor immune microenvironment. This evidence concerns the gene AKR1B10 and hepatocellular carcinoma.